These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6990956)

  • 1. A quantitative model for subcutaneous abscess formation in mice.
    Joiner KA; Onderdonk AB; Gelfand JA; Bartlett JG; Gorbach SL
    Br J Exp Pathol; 1980 Feb; 61(1):97-107. PubMed ID: 6990956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents.
    Nulsen MF; Finlay-Jones JJ; Skinner JM; McDonald PJ
    Br J Exp Pathol; 1983 Aug; 64(4):345-53. PubMed ID: 6311236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused ultrasound treatment of abscesses induced by methicillin resistant Staphylococcus aureus: feasibility study in a mouse model.
    Rieck B; Bates D; Zhang K; Escott N; Mougenot C; Pichardo S; Curiel L
    Med Phys; 2014 Jun; 41(6):063301. PubMed ID: 24877838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritonitis induced by Bacteroides fragilis.
    Woltmann A; Gangloff SC; Bruch HP; Rietschel ET; Solbach W; Silver J; Goyert SM
    Med Microbiol Immunol; 1999 Mar; 187(3):149-56. PubMed ID: 10206146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism between Bacteroides fragilis and Staphylococcus aureus in experimental tibial osteomyelitis.
    Rissing JP; Buxton TB; Horner JA; Shockley RK; Fisher JF; Harris R
    J Lab Clin Med; 1987 Oct; 110(4):433-8. PubMed ID: 3655522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ofloxacin (HOE 280) in a model of subcutaneous abscess: penetration and prevention of abscess formation.
    GarcĂ­a Iglesias MC; Perea EJ
    Infection; 1986; 14 Suppl 4():S266-9. PubMed ID: 3546146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host factors in the formation of abscesses.
    Joiner KA; Gelfand JA; Onderdonk AB; Bartlett JG; Gorbach SL
    J Infect Dis; 1980 Jul; 142(1):40-9. PubMed ID: 7400627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of murine intra-abdominal abscess formation.
    Cheadle WG; Hershman MJ; Pietsch JD; Logan WA; Polk HC
    Arch Surg; 1988 Nov; 123(11):1342-6. PubMed ID: 3178482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaerobic infection of the liver and biliary tract in experimental common duct occlusion.
    Justesen T; Nielsen ML
    Scand J Infect Dis Suppl; 1979; (19):35-41. PubMed ID: 379988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers.
    Ford CW; Hamel JC; Stapert D; Yancey RJ
    J Med Microbiol; 1989 Apr; 28(4):259-66. PubMed ID: 2467987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of the size and clone of an intra-abdominal abscess in rats.
    Nakatani T; Sato T; Trump BF; Siegel JH; Kobayashi K
    Res Exp Med (Berl); 1996; 196(2):117-26. PubMed ID: 8739801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental model for pyogenic liver abscess.
    McDonald MI; Lucore CL; Durack DT
    J Infect; 1984 Mar; 8(2):129-36. PubMed ID: 6373947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does heparin modify the course of chronic abscess-forming peritonitis in the animal model?].
    Woltmann A; Kattenbeck K; Broll R; Lebeau A; Gatermann S; Bruch HP
    Langenbecks Arch Chir; 1997; 382(2):107-10. PubMed ID: 9198703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of corticosteroids on subcutaneous abscess formation in the mouse.
    Joiner KA; Gelfand JA; Bartlett JG; Gorbach SL
    Br J Exp Pathol; 1981 Jun; 62(3):222-6. PubMed ID: 7248166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.